Hepatitis Forums
Hepatitis B Main Forums => Hepatitis B => Topic started by: Hep Editors on February 25, 2019, 11:05:41 am
-
The Food and Drug Administration (FDA) has revised the drug label for Viread (tenofovir disoproxil fumarate) to account for 48-week data from two recent randomized trials of the drug’s use for treatment of hepatitis B virus (HBV) in children 2 through 11 years old.
The studies known as Trial 144 and Trial 115 included children with hep B who were at least 2 years old but who had not reached 12 years old.
Read more...
https://www.hepmag.com/article/viread-label-revised-address-treatment-hep-b-children